Skip to main content
. 2013 Nov 15;48(2):130–136. doi: 10.1007/s13139-013-0248-y

Table 3.

Results for SUVmax, SUVmean, and serum SCC level pre- and post-treatment for patients with FDG uptake equal to or higher than 4.0

Patients with
complete response (n = 7)
Patients with
residual tumor (n = 11)
Pre-treatment SUVmax 12.0 ± 3.9 19.3 ± 10.9 NS
SUVmean 8.8 ± 3.2 13.3 ± 6.9 NS
SCC (ng/ml) 7.7 ± 10.3 32.3 ± 71.0 NS
Post-treatment SUVmax 4.4 ± 0.4 5.9 ± 2.7 NS
SUVmean 2.9 ± 0.5 3.8 ± 1.8 NS
SCC (ng/ml) 0.6 ± 0.3 3.9 ± 4.3 p < 0.05